ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹2,294 Cr | ₹3,333 Cr | ₹1,903 Cr | ₹1,819 Cr | ₹2,650 Cr |
What is the latest Net Current Assets ratio of ABBOTT INDIA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹2,294 Cr |
| Mar2025 | ₹3,333 Cr |
| Mar2024 | ₹1,903 Cr |
| Mar2023 | ₹1,819 Cr |
| Mar2022 | ₹2,650 Cr |
How is Net Current Assets of ABBOTT INDIA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,294 Cr | -31.16 | |
| Mar2025 | ₹3,333 Cr | 75.12 | |
| Mar2024 | ₹1,903 Cr | 4.62 | |
| Mar2023 | ₹1,819 Cr | -31.35 | |
| Mar2022 | ₹2,650 Cr | - | |
Compare Net Current Assets of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,900.4 Cr | -0.9% | -6.8% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.9% |
-6.8% |
-19.4% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses